Integrated care for fatigue in young breast cancer and germ cell tumor patients
Pilot Project for the Implementation of an Integrated Multidisciplinary Follow-up for Young Patients With Breast Cancer or Germ Cell Tumor
This study is trying a team approach to help young adults who have finished treatment for breast cancer or germ cell tumors manage their fatigue and improve their daily lives.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 39 Years |
| Sex | All |
| Sponsor | Jules Bordet Institute Academic / other |
| Locations | 1 site (Brussels) |
| Trial ID | NCT05502224 on ClinicalTrials.gov |
What this trial studies
This study implements a multidisciplinary approach to evaluate and manage fatigue in young patients aged 18 to 39 who have completed acute treatment for breast cancer or germ cell tumors. Patients will undergo a comprehensive evaluation by a team consisting of an oncologist, psychologist, physiotherapist, dietician, and nurse-coach, focusing on identifying both organic and psychological factors contributing to their fatigue. The evaluation will assess the impact of fatigue on daily life and physical activity levels, leading to a personalized management plan that will be discussed and coordinated with the patient. The goal is to improve the quality of life for these patients through tailored interventions.
Who should consider this trial
Good fit: Ideal candidates are young adults aged 18 to 39 who have completed acute treatment for curative breast cancer or germ cell tumors and experience moderate to severe fatigue.
Not a fit: Patients with stage IV breast cancer or those participating in other psychosocial intervention studies may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the quality of life for young cancer survivors by effectively managing fatigue.
How similar studies have performed: While similar multidisciplinary approaches have shown promise in managing cancer-related fatigue, this specific integrated model is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 39 years at the time of signing the informed consent * Patient who speaks and understands French * Signed study informed consent form obtained prior to any study related procedures * At minimum, a moderate (\>3) fatigue level according to the Standard Rating Scale (NRS) 1 month after completion of acute treatment; as measured at the Survivorship of the standard program * Patient with either: curative breast cancer (AJCC stage I-II-III) or a germ cell tumor Exclusion Criteria: * Refusal to participate in the study * Patient having chosen to participate in another psychosocial intervention study for the duration of the study. * Patients with AJCC stage IV breast cancer
Where this trial is running
Brussels
- Institut Jules Bordet — Brussels, Belgium (Recruiting)
Study contacts
- Study coordinator: Laura Polastro, MD
- Email: laura.polastro@bordet.be
- Phone: +3225413279
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.